According to a presentation at the Society of Gynecologic Oncology, federal funding for medical research shortchanges gynecologic oncology when cancer lethality is taken into account. Among 13 common cancers included in the analysis, gynecologic cancers ranked near the bottom in National Cancer Institute (NCI) funding support, as measured by spending per years of life lost (YLL).